Center-Authored Papers

Filters: Author is Hayes, Daniel F  [Clear All Filters]
Journal Article
Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goldstein LJ et al..  2014.  Breast cancer version 3.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(4):542-90. Abstract
Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ et al..  2013.  Breast cancer, version 3.2013: featured updates to the NCCN guidelines.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(7):753-60;quiz761. Abstract
Smerage JB, Barlow WE, Hortobagyi GN, Winer EP, Leyland-Jones B, Srkalovic G, Tejwani S, Schott AF, O'Rourke MA, Lew DL et al..  2014.  Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB et al..  2012.  Combination anastrozole and fulvestrant in metastatic breast cancer.. The New England journal of medicine. 367(5):435-44. Abstract
Hertz DL, Barlow WE, Kidwell KM, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Livingston RB, Gralow J, Hayes DF et al..  2016.  Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.. British journal of clinical pharmacology. Abstract
Somerfield MR, Bohlke K, Browman GP, Denduluri N, Einhaus K, Hayes DF, Khorana AA, Miller RS, Mohile SG, Oliver TK et al..  2016.  Innovations in American Society of Clinical Oncology Practice Guideline Development.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Polley M-YC, Leung SCY, Gao D, Mastropasqua MG, Zabaglo LA, Bartlett JMS, McShane LM, Enos RA, Badve SS, Bane AL et al..  2015.  An international study to increase concordance in Ki67 scoring.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. Abstract
Carlson RW, Allred CD, Anderson BO, Burstein HJ, Carter BW, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH et al..  2011.  Invasive breast cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(2):136-222.
Carlson RW, Allred CD, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ et al..  2012.  Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(7):821-9. Abstract
Harigopal M, Barlow WE, Tedeschi G, Porter PL, Yeh I-T, Haskell C, Livingston R, Hortobagyi GN, Sledge G, Shapiro C et al..  2010.  Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.. The American journal of pathology. 176(4):1639-47. Abstract
Tubbs R, Barlow WE, Budd TG, Swain E, Porter PL, Gown A, Yeh I-T, Sledge G, Shapiro C, Ingle J et al..  2009.  Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(24):3881-6. Abstract
Schott AF, Barlow WE, Van Poznak CH, Hayes DF, Moinpour CM, Lew DL, Dy PA, Keller ET, Keller JM, Hortobagyi GN.  2016.  Phase II studies of two different schedules of dasatinib in ***bone metastasis predominant metastatic breast cancer: SWOG S0622.. Breast cancer research and treatment. Abstract
Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow JR, Hortobagyi GN, Livingston R.  2008.  A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.. Clinical breast cancer. 8(6):511-5. Abstract
Henry LN, Hayes DF, Ramsey SD, Hortobagyi GN, Barlow WE, Gralow JR.  2014.  Promoting Quality and Evidence-Based Care in Early-Stage Breast Cancer Follow-up.. Journal of the National Cancer Institute. Abstract